Clinical trial

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH)…

NCT00062348 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00062348
Title Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Official title B-Uptake In Different Tumours Using The Boron Compounds BSH And BPA
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Colorectal Cancer, Head and Neck Cancer, Metastatic Cancer
Intervention type Drug, Procedure
Interventions boronophenylalanine-fructose complex, sodium borocaptate, conventional surgery
Enrollment 27
Start date Apr 1, 2003
Primary completion Dec 1, 2007
First posted Jun 6, 2003
Last update posted Jan 20, 2012
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies